Proprioceptive Postural Control and Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT01505543
Last Updated: 2013-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2012-01-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to clarify whether proprioceptive postural control is impaired in individuals with chronic obstructive pulmonary disease.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic obstructive pulmonary disease
No interventions assigned to this group
healthy matched controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spirometry (post-bronchodilator) based diagnosis of COPD (GOLD criteria)
* Willingness to sign the informed consent
* Age: 40-80 years old
* No COPD (spirometry based: FEV1/FVC ≥ 0.7 and FEV1 \> 80%)
* Willingness to sign the informed consent
Exclusion Criteria
* One of the following conditions: Parkinson, multiple sclerosis, stroke, history of vestibular disorder
* Respiratory disorder other than COPD
* α1-antitrypsin deficiency
* Known history of significant inflammatory disease other than COPD
* COPD exacerbation within 4 weeks prior to study
* Lung surgery
* Recent diagnosis of cancer
* Therapy with oral corticosteroids in the last 6 weeks
* Significant cardiovascular comorbidity
40 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Brumagne
Prof. dr. Simon Brumagne
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Brumagne, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Thierry Troosters, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Wim Janssens, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Marc Decramer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Katholieke Universiteit Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Janssens L, Brumagne S, Polspoel K, Troosters T, McConnell A. The effect of inspiratory muscles fatigue on postural control in people with and without recurrent low back pain. Spine (Phila Pa 1976). 2010 May 1;35(10):1088-94. doi: 10.1097/BRS.0b013e3181bee5c3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.5.104.03, G.0674.09
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2012_SBrumagne_COPD
Identifier Type: -
Identifier Source: org_study_id